Castle Biosciences logo

Castle Biosciences

CSTL | NASDAQ
Chart Builder DCF Calculator
$32.75
-$1.04 (-3.08%)
At close: Nov 16, 2026, 4:00 PM ET
$32.75
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-3.08%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.5
+1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #643/1021 (Top 63%)

Key Statistics

Market Data

Market Cap $1.01B
1D Range
32.46 33.65
52W Range
18.15 43.04

Valuation (TTM)

PE -42.53
PB 2.11
EV/EBITDA -125.61

Valuation (NTM)

Forward PE N/A
Forward PEG 2.11
Price Target $38.00
Loading financial charts...

Profile

Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting var...

Sector Healthcare
Employees 1,002
IPO Date Jul 25, 2019
Fiscal Year January - December

Latest News

Castle Biosciences Earns 2026 Top Workplaces Awards Recognizing Its People-First Culture

4 days ago · prnewswire.com

Castle Biosciences Earns 2026 Top Workplaces Awards Recognizing Its People-First Culture
Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference

5 days ago · prnewswire.com

Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference
DecisionDx®-Melanoma Data at SDPA and Dermato-Onco2026 Support the Test's Ability to Refine Risk Assessment Beyond AJCC Staging

5 days ago · prnewswire.com

DecisionDx®-Melanoma Data at SDPA and Dermato-Onco2026 Support the Test's Ability to Refine Risk Assessment Beyond AJCC Staging
Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 37%: Here's is How to Trade

6 days ago · zacks.com

Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 37%: Here's is How to Trade
What Castle Biosciences (CSTL) Said on Its Q3 Earnings Call

11 days ago · marketbeat.com

What Castle Biosciences (CSTL) Said on Its Q3 Earnings Call
Castle Biosciences, Inc. (CSTL) Q3 2026 Earnings Call Transcript

11 days ago · seekingalpha.com

Castle Biosciences, Inc. (CSTL) Q3 2026 Earnings Call Transcript
Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Beats Revenue Estimates

11 days ago · zacks.com

Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Beats Revenue Estimates
Castle Biosciences Reports Third Quarter 2026 Results

11 days ago · prnewswire.com

Castle Biosciences Reports Third Quarter 2026 Results
Castle Biosciences to Participate in Upcoming Investor Conferences

20 days ago · prnewswire.com

Castle Biosciences to Participate in Upcoming Investor Conferences
Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026

1 month ago · prnewswire.com

Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.13
Beat +62.64%
REV
$101.95M
Beat +9.90%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$38.00
Upside
+16.03%
Buy (6)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.